Oral Abstract Session:
121. Pneumonia from Soup to Nuts
Friday, October 28, 2016: 8:30 AM-10:00 AM
Room: 288-290

Learning Objectives:

-

Tracks: Adult ID

Moderators:  Robert Atmar, MD, FIDSA, FSHEA, Baylor College of Medicine and Andrew Pavia, MD, FIDSA, FSHEA, FPIDS, University of Utah School of Medicine

Presentations:
8:30 AM
905
Host Transcriptomic Signatures for Early Diagnosis of Acute Respiratory Viral Infection in a University-based Index-Cluster Cohort
Micah T. Mcclain, MD, PhD ; Christopher W Woods, MD, MPH, FIDSA ; Ephraim L. Tsalik, MD, MHS, PhD ; Geoffrey S. Ginsburg, MD, PhD ; Bradly P. Nicholson, PhD ; Thomas Burke, PhD ; Lori Hudson, PhD ; Timothy Veldman, PhD ; Olga Better, RA ; Stephanie Dobos, BA ; Sunil Suchindran, PhD ; Marshall Nichols, MS ; Ashlee Valente, PhD ; Lawrence Park, PhD ; Ricardo Henao, PhD
8:45 AM
906
Do Antiplatelet Medications Prevent Poor Clinical Outcomes in Patients with Community-Acquired Pneumonia? Results from the CAPO International Cohort Study
Paula Peyrani, MD ; Timothy Wiemken, PhD ; Robert Kelley, PhD ; Anupama Raghuram, MD ; Forest Arnold, DO, MSc, FIDSA ; Stefano Aliberti, MD ; James Chalmers, MD ; Marcos I. Restrepo, MD, MSc ; Jose Bordon, MD, PhD ; Julio Ramirez, MD
9:00 AM
907
Clinical characteristics and outcomes of patients with Community-Acquired Pneumonia - Real-Life Versus FDA Trials: Results from the CAPO International Cohort Study
Paula Peyrani, MD ; Anupama Raghuram, MD ; Forest Arnold, DO, MSc, FIDSA ; Timothy Wiemken, PhD ; Robert Kelley, PhD ; Marcos I. Restrepo, MD, MSc ; Jose Bordon, MD, PhD ; Stefano Aliberti, MD ; James Chalmers, MD ; Julio Ramirez, MD
9:15 AM
908
Optimization of Pneumonia Treatment in an Intensive Care Unit Utilizing a Pharmacist-Driven Protocol
Maureen Campion, PharmD ; Kevin Sponsel, PharmD, BCPS ; Andrea H Stock, PharmD, BCPS ; Imad Shawa, MD ; Richard Need, MD ; S. Christian Cheatham, PharmD
9:30 AM
909
The Burden of Pneumococcal Community-Acquired Pneumonia and Invasive Pneumococcal Disease in Hospitalized Adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network Study
Jason Leblanc, PhD ; May Elsherif, MD ; Donna Mackinnon-Cameron, MMath ; Lingyun Ye, PhD ; Ardith Ambrose, RN ; Irene Martin, BSc ; Haley Gillis, BSc ; Amanda Lang, PhD ; Melissa K Andrew, MD, PhD ; Guy Boivin, MD, MSc ; William Bowie, MD, FRCPC, FIDSA ; Karen Green, MSc ; Todd Hatchette, MD ; Jennie Johnstone, MD ; Mark Loeb, MD, MSc ; Anne E. Mccarthy, MD ; Allison Mcgeer, MD, MSc ; Sanela Moraca, MHSc ; Makeda Semret, MD ; Grant Stiver, MD ; Sylvie Trottier, MD ; Louis Valiquette, MD, MSc ; Duncan Webster, MD ; Shelly a Mcneil, MD, FRCPC, FIDSA
9:45 AM
910
Influenza Vaccine Effectiveness in the Prevention of Influenza-related Hospitalization in Canadian Adults Over the 2011/12 through 2013/14 Season: A Pooled Analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)
Shelly a Mcneil, MD, FRCPC, FIDSA ; Todd Hatchette, MD ; Melissa K Andrew, MD, PhD ; Ardith Ambrose, RN ; Guy Boivin, MD, MSc ; Francisco Diaz-Mitoma, MD, PhD ; William Bowie, MD, FRCPC, FIDSA ; Ayman Chit, MBiotech, PhD ; Gael Dos Santos, PhD ; May Elsherif, MD ; Karen Green, MSc ; Francois Haguinet, PhD ; Scott a. Halperin, MD ; Barbara Ibarguchi, MSc ; Jennie Johnstone, MD ; Kevin Katz, MD, CM, MSc, FRCPC ; Joanne M. Langley, MD, FRCPC, FSHEA ; Jason Leblanc, PhD ; Philippe Lagace-Wiens, MD ; Bruce Light, MD ; Mark Loeb, MD, MSc ; Donna Mackinnon-Cameron, MMath ; Anne E. Mccarthy, MD ; Janet E. Mcelhaney, MD ; Allison Mcgeer, MD, MSc ; Andre Poirier, MD, MSc ; Jeff Powis, MD, MSc, FRCPC ; David Richardson, MD ; Makeda Semret, MD ; Vivek Shinde, MD, MPH ; Stephanie Smith, MD, MSc ; Daniel Smyth, MD, FRCPC ; Grant Stiver, MD ; Geoff Taylor, MD ; Sylvie Trottier, MD ; Louis Valiquette, MD, MSc ; Duncan Webster, MD ; Lingyun Ye, PhD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.